+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Screening Market - Global Forecast 2026-2032- Product Image
Blood Screening Market - Global Forecast 2026-2032- Product Image
New

Blood Screening Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083561
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The blood screening market is undergoing strategic transformation, shaped by evolving laboratory priorities, regulatory shifts, and the increasing integration of advanced diagnostics. Senior leaders must navigate these changes to ensure resilience, efficiency, and clinical excellence in testing programs.

Market Snapshot: Blood Screening Market Growth and Dynamics

The Blood Screening Market grew from USD 5.79 billion in 2025 to USD 6.31 billion in 2026. It is expected to continue growing at a CAGR of 9.07%, reaching USD 10.64 billion by 2032. This robust growth reflects heightened demand for faster, more precise, and scalable blood testing across health systems worldwide.

Scope & Segmentation

  • Test Types: Includes Hepatitis B, Hepatitis C, HIV, and Syphilis Screening, each with specific assay, workflow, and compliance requirements.
  • Technologies: Features Chemiluminescence, Flow Cytometry, Immunoassays (including Chemiluminescence Immunoassay, Enzyme Linked Immunosorbent Assay, Radioimmunoassay), and Molecular Diagnostics (such as Isothermal Amplification, Next Generation Sequencing, Polymerase Chain Reaction), each balancing throughput, cost, and analytical performance.
  • End Users: Blood Banks, Clinics, Diagnostic Laboratories, and Hospitals, all bringing unique procurement, validation, and onboarding dynamics.
  • Sample Types: Plasma, Serum, and Whole Blood, influencing handling, compatibility, and operational efficiency.
  • Testing Modes: Lab Based and Point Of Care, each informing investment in equipment portability, user training, and IT connectivity.
  • Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific, where regulatory models, infrastructure maturity, and adoption patterns differ significantly.

Key Takeaways: Strategic Drivers and Market Evolution

  • Blood screening sits at the intersection of public health, clinical care, and laboratory innovation, elevating its value from operational necessity to a strategic health system asset.
  • Laboratory leaders are demanding solutions that reduce turnaround times and boost accuracy, while procurement teams prioritize seamless integration with health and laboratory information systems.
  • Technological advancements—such as high-sensitivity molecular diagnostics and next-generation sequencing—are expanding both the depth and speed of screening, enabling early pathogen detection and improved outcomes.
  • Demographic changes, emerging infectious threats, and ongoing vendor consolidation are prompting organizations to revisit quality assurance protocols and update procurement models for long-term agility.
  • Point-of-care testing and interoperable lab information systems are shifting diagnostic pathways, supporting fast results in emergency and decentralized settings while reducing manual workload.
  • Vendor strategies increasingly focus on automation, remote monitoring, and localized manufacturing to support service excellence and compliance with shifting regional and regulatory requirements.

Tariff Impact & Supply Chain Strategies

Recent shifts in tariff regimes and trade policies are influencing procurement and operational resilience. Elevated duties and extended lead times encourage laboratories and manufacturers to diversify suppliers, expand local sourcing, and incorporate flexibility into contract terms. Manufacturers are localizing assembly and adjusting reagent formulations to navigate cost and compliance pressures, requiring updated quality validation. These adjustments reinforce the importance of contingency planning and robust supplier monitoring to maintain screening continuity.

Methodology & Data Sources

This report applies a multi-method research approach, combining primary interviews with laboratory leaders and procurement experts, secondary analysis of regulatory guidelines, product documentation, and peer-reviewed studies. Findings are validated with operational case studies and technical reports to deliver actionable and reliable insights for industry stakeholders.

Why This Report Matters

  • Enables executives to align investment strategies with evolving screening technologies, supply chain realities, and regulatory environments.
  • Delivers segmentation and regional analysis to inform product positioning, resource allocation, and entry strategies for varied end-users and geographies.
  • Supports data-driven decision making by linking operational, clinical, and commercial priorities across the full spectrum of blood screening stakeholders.

Conclusion

Success in blood screening will favor organizations that align innovation with resilient operations and regulatory compliance. Strategic investment in modular, interoperable platforms positions stakeholders to meet diverse needs and adapt to future diagnostic challenges.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Blood Screening Market, by Test Type
8.1. Hepatitis B Screening
8.2. Hepatitis C Screening
8.3. HIV Screening
8.4. Syphilis Screening
9. Blood Screening Market, by Technology
9.1. Chemiluminescence
9.2. Flow Cytometry
9.3. Immunoassays
9.3.1. Chemiluminescence Immunoassay
9.3.2. Enzyme Linked Immunosorbent Assay
9.3.3. Radioimmunoassay
9.4. Molecular Diagnostics
9.4.1. Isothermal Amplification
9.4.2. Next Generation Sequencing
9.4.3. Polymerase Chain Reaction
10. Blood Screening Market, by Sample Type
10.1. Plasma
10.2. Serum
10.3. Whole Blood
11. Blood Screening Market, by Testing Mode
11.1. Lab Based
11.2. Point Of Care
12. Blood Screening Market, by End User
12.1. Blood Banks
12.2. Clinics
12.3. Diagnostic Laboratories
12.4. Hospitals
13. Blood Screening Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Blood Screening Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Blood Screening Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Blood Screening Market
17. China Blood Screening Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Becton, Dickinson and Company
18.7. Bio-Rad Laboratories, Inc.
18.8. bioMérieux SA
18.9. Danaher Corporation
18.10. F. Hoffmann-La Roche Ltd
18.11. Grifols, S.A.
18.12. Hologic, Inc.
18.13. Merck KGaA
18.14. Ortho Clinical Diagnostics, Inc.
18.15. QIAGEN N.V.
18.16. Siemens Healthineers AG
18.17. Terumo BCT, Inc.
18.18. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL BLOOD SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BLOOD SCREENING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BLOOD SCREENING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BLOOD SCREENING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BLOOD SCREENING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES BLOOD SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA BLOOD SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BLOOD SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BLOOD SCREENING MARKET SIZE, BY HEPATITIS B SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BLOOD SCREENING MARKET SIZE, BY HEPATITIS B SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BLOOD SCREENING MARKET SIZE, BY HEPATITIS B SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BLOOD SCREENING MARKET SIZE, BY HEPATITIS C SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BLOOD SCREENING MARKET SIZE, BY HEPATITIS C SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BLOOD SCREENING MARKET SIZE, BY HEPATITIS C SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BLOOD SCREENING MARKET SIZE, BY HIV SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BLOOD SCREENING MARKET SIZE, BY HIV SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BLOOD SCREENING MARKET SIZE, BY HIV SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BLOOD SCREENING MARKET SIZE, BY SYPHILIS SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BLOOD SCREENING MARKET SIZE, BY SYPHILIS SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BLOOD SCREENING MARKET SIZE, BY SYPHILIS SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BLOOD SCREENING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BLOOD SCREENING MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BLOOD SCREENING MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BLOOD SCREENING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BLOOD SCREENING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BLOOD SCREENING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BLOOD SCREENING MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BLOOD SCREENING MARKET SIZE, BY RADIOIMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BLOOD SCREENING MARKET SIZE, BY RADIOIMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BLOOD SCREENING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BLOOD SCREENING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BLOOD SCREENING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BLOOD SCREENING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BLOOD SCREENING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BLOOD SCREENING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BLOOD SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BLOOD SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BLOOD SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BLOOD SCREENING MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BLOOD SCREENING MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BLOOD SCREENING MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BLOOD SCREENING MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BLOOD SCREENING MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BLOOD SCREENING MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BLOOD SCREENING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BLOOD SCREENING MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BLOOD SCREENING MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BLOOD SCREENING MARKET SIZE, BY LAB BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BLOOD SCREENING MARKET SIZE, BY LAB BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BLOOD SCREENING MARKET SIZE, BY LAB BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BLOOD SCREENING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BLOOD SCREENING MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BLOOD SCREENING MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BLOOD SCREENING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BLOOD SCREENING MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BLOOD SCREENING MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BLOOD SCREENING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BLOOD SCREENING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BLOOD SCREENING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BLOOD SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BLOOD SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BLOOD SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BLOOD SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BLOOD SCREENING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BLOOD SCREENING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS BLOOD SCREENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. EUROPE BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. EUROPE BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 113. EUROPE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 114. EUROPE BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 115. EUROPE BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 116. EUROPE BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 117. EUROPE BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2032 (USD MILLION)
TABLE 118. EUROPE BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. AFRICA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 129. AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 130. AFRICA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 131. AFRICA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 132. AFRICA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 133. AFRICA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2032 (USD MILLION)
TABLE 134. AFRICA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL BLOOD SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. ASEAN BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. ASEAN BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 146. ASEAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 147. ASEAN BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 148. ASEAN BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 149. ASEAN BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 150. ASEAN BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2032 (USD MILLION)
TABLE 151. ASEAN BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. GCC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GCC BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 154. GCC BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 155. GCC BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 156. GCC BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 157. GCC BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 158. GCC BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2032 (USD MILLION)
TABLE 159. GCC BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. BRICS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. BRICS BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 170. BRICS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 171. BRICS BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 172. BRICS BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 173. BRICS BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 174. BRICS BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2032 (USD MILLION)
TABLE 175. BRICS BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. G7 BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. G7 BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 178. G7 BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 179. G7 BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 180. G7 BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 181. G7 BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 182. G7 BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2032 (USD MILLION)
TABLE 183. G7 BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. NATO BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. NATO BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 186. NATO BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 187. NATO BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 188. NATO BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 189. NATO BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 190. NATO BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2032 (USD MILLION)
TABLE 191. NATO BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. UNITED STATES BLOOD SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 194. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 195. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 196. UNITED STATES BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 197. UNITED STATES BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 198. UNITED STATES BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 199. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2032 (USD MILLION)
TABLE 200. UNITED STATES BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. CHINA BLOOD SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 202. CHINA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 203. CHINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 204. CHINA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 205. CHINA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 206. CHINA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 207. CHINA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2032 (USD MILLION)
TABLE 208. CHINA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Blood Screening market report include:
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Grifols, S.A.
  • Hologic, Inc.
  • Merck KGaA
  • Ortho Clinical Diagnostics, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages187
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.31 Billion
Forecasted Market Value ( USD ) by 2032 $ 10.64 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Blood Screening Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Blood Screening Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 210 Pages
  • Global
From
Blood Screening - Global Strategic Business Report - Product Image

Blood Screening - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Blood Screening Market Report 2025 - Product Image

Blood Screening Market Report 2025

  • Report
  • 200 Pages
  • Global
From
2025 Global Forecast for Blood Screening Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Blood Screening Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Blood Transfusion Diagnostics Market - Global Forecast 2026-2032 - Product Image

Blood Transfusion Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From

About the Blood Screening Market

The Blood Screening market within the context of In Vitro Diagnostics is a rapidly growing sector of the healthcare industry. It involves the use of laboratory tests to detect and diagnose diseases and other medical conditions. These tests are used to detect a wide range of conditions, including infections, genetic disorders, and cancer. Blood screening tests are used to detect the presence of antibodies, antigens, and other markers that can indicate the presence of a disease or condition. Blood screening tests are used in a variety of settings, including hospitals, clinics, and laboratories. They are also used in research and development, as well as in the development of new treatments and therapies. Blood screening tests are used to monitor the health of patients, as well as to detect and diagnose diseases and other medical conditions. Some of the major companies in the Blood Screening market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, and Roche Diagnostics. These companies provide a wide range of products and services, including diagnostic tests, reagents, and instruments. They also offer a variety of services, such as consulting, training, and support. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.